Intelligence Ventures is a pre-seed and seed-stage fund built on a simple premise: the best investments in AI healthcare come from studying the space deeper than anyone else.



Before we wrote our first check, we spent years mapping the earliest-stage AI healthcare pipeline in North America, company by company, deck by deck. We published what we learned. We still do. That research is what drives every investment decision we make.



We invest across four verticals where AI is reshaping healthcare: biotech and pharma tools, medical devices, diagnostics, and healthcare SaaS. US and Canada. Our filter is simple: if your core advantage is a proprietary dataset that makes your models smarter over time, we want to talk.



If AI is a feature and not the product, we're probably not the right fit.



Our pipeline grows by 20-30 new companies every week through inbound alone. Our acceptance rate is below 1%. Not as a vanity metric, but because we've studied this landscape long enough to know what works.



Founders: apply at intelligencevc.com. LPs: read our research first. We'd rather you judge our thesis than take our word for it.